TrialEndocrine-related cancer2018

Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict's value.

Louis W C Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.